Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus standard therapy for prevention of recurrent variceal bleeding in cirrhosis
2009-016500-24Phase 3Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and esophageal varices comparing Simvastatin + standard therapy with Placebo + standard therapy (2 arms). Primary endpoint: Time to recurrent bleeding or death. Started Jan 2010; status: completed.
02
Drugs
simvastatin
03
Conditions
Cirrhosisesophageal varices
Beyond the preview
Go deeper on 2009-016500-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016500-24.